Literature DB >> 6429252

Adherence of Candida species to human epidermal corneocytes and buccal mucosal cells: correlation with cutaneous pathogenicity.

T L Ray, K B Digre, C D Payne.   

Abstract

Adherence of microorganisms to epidermal corneocytes may be a prerequisite for cutaneous colonization and infection. Six species of Candida were assayed in vitro for adherence to human epidermal corneocytes and buccal mucosal cells, and compared to previous studies of pathogenicity in a rodent model of cutaneous candidiasis. C. albicans and C. stellatoidea exhibited marked adherence to both epithelial cell types over time, and were cutaneous pathogens in the rodent model. The remaining species showed little or no adherence, and were nonpathogenic to skin. Adherence to corneocytes was not inhibited by ethylenediamine tetraacetic acid, mannan polysaccharide, or concanavalin A lectin. Fresh human serum, but not heat-inactivated serum, inhibited C. albicans adherence by 50%, and was associated with the deposition of complement components, C3 and factor B on blastospores. Adherence to epithelial corneocytes and mucosal cells is a property of pathogenic species of Candida, and may participate in cutaneous colonization and infection mechanisms. Adherence was time-dependent, and did not require divalent cations. Cell wall mannan may participate in the "adhesin" complex. Mannan activation of serum complement and deposition of C3 and factor B on blastospores may provide a protective action by inhibiting Candida adherence to corneocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429252     DOI: 10.1111/1523-1747.ep12261661

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  19 in total

Review 1.  Adherence and receptor relationships of Candida albicans.

Authors:  R A Calderone; P C Braun
Journal:  Microbiol Rev       Date:  1991-03

2.  Adherence of Candida species to fibrin clots in vitro.

Authors:  L P Samaranayake; L McLaughlin; T MacFarlane
Journal:  Mycopathologia       Date:  1988-05       Impact factor: 2.574

3.  Comparative production and rapid purification of Candida acid proteinase from protein-supplemented cultures.

Authors:  T L Ray; C D Payne
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

4.  Adherence of cell surface mutants of Candida albicans to buccal epithelial cells and analyses of the cell surface proteins of the mutants.

Authors:  M Fukayama; R A Calderone
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

5.  Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes.

Authors:  M W Ollert; R Söhnchen; H C Korting; U Ollert; S Bräutigam; W Bräutigam
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

6.  Characterization of a major cell wall antigen and potential adhesin in three strains of Candida albicans.

Authors:  W Jenq; C L Chen; C C Chang; R F Crang
Journal:  Arch Microbiol       Date:  1994       Impact factor: 2.552

7.  Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients.

Authors:  M W Ollert; C Wende; M Görlich; C G McMullan-Vogel; M Borg-von Zepelin; C W Vogel; H C Korting
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

8.  The influence of post-filtration washing on the in vitro assay of Candida albicans adherence to human buccal epithelial cells.

Authors:  E D Theaker; D B Drucker; A C Gibbs
Journal:  Mycopathologia       Date:  1993-01       Impact factor: 2.574

9.  Factors influencing the interaction of Candida albicans with fibroblast cell cultures.

Authors:  G J Merkel; C L Phelps
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

10.  Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase.

Authors:  T L Ray; C D Payne
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.